The Cold Chain Challenge of mRNA Vaccines

Millions of doses of the Pfizer-BioNTech vaccine, just days ago granted emergency use authorization by the FDA, are being distributed across the country. It's the first widely-available vaccine to use something called mRNA technology. So, with the help of epidemiologist Rene Najera, Maddie explains the science behind this vaccine and how it was developed so quickly.

Email the show at shortwave@npr.org.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy